Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 7/17/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Jeffrey Lieberman?

Jeffrey A. Lieberman

Chairman of Psychiatry

Columbia Presbyterian Medical Center

HQ Phone:  (212) 854-8444

Direct Phone: (646) ***-****direct phone

Email: j***@***.edu

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Columbia Presbyterian Medical Center

1051 Riverside Drive Unit 30

New York City, New York,10032

United States

Company Description

A leading academic and research university, Columbia University continually seeks to advance the frontiers of knowledge and to foster a campus community deeply engaged in understanding and addressing the complex global issues of our time. Columbia University's...more

Background Information

Employment History

Executive Director

Coalition of Institutionalized Aged & Disabled


Director

New York State Psychiatric Institute


Director of New York State Psychiatric Institute

New York State Department


Affiliations

Fountain House Inc

Medical Advisory Board Member


Dana Foundation Inc

Member


College Re-Entry

Medical Advisory Board Member


PsychoGenics Inc

Scientific Advisory Board Member


Long Term Care Community Coalition

Board Member


Clintara LLC

Scientific Advisory Board Member


National Academy of Sciences

Member


American Association for the Advancement of Science

Fellow


Treatment Advocacy Center

Board Member


Intra-Cellular Therapies, Inc.

Advisory Boards


Pear Therapeutics

Advisory Board Member


Skyland Trail

National Advisory Board Member


AstraZeneca PLC

Advisory Boards


Lundbeck Inc

Advisory Boards


Organon Inc.

Advisory Boards


CNS Spectrums

Advisory Board Member


Lundbeck Inc

Member, Advisory Boards


GlaxoSmithKline plc

Member, Advisory Boards


Eli Lilly and Company

Member, Advisory Boards


Organon Inc.

Member, Advisory Boards


Pfizer Inc

Member, Advisory Boards


GlaxoSmithKline plc

Advisory Boards


American Psychiatric Association

President


Pierre Fabre

Advisory Boards


PsychoGenics Inc

Advisory Boards


CME Outfitters , LLC

Clinical Advisory Board Member


American College of Neuropsychopharmacology

Co-Chairperson of the Ethics Committee


Bioline

Advisory Boards


Wyeth Pharmaceuticals

Advisory Boards


American Foundation for Suicide Prevention

Scientific Advisor


The Chatham Institute

Advisory Board Member


PRIMEDIA Workplace Learning

Advisory Board Member


National Alliance for Research on Schizophrenia and Depression Inc

Scientific Council Member


Institute of Medicine

Member


neuroscienceCME.com

Clinical Advisory Board


Foundation Scientific Council

Member


PRIMEDIA Healthcare

Advisory Board Member


PRIMEDIA Inc

Member of Advisory Board


World Psychiatric Association Editorial Committee for Position Paper on Atypical Antipsychotic Drugs

Member


Miller Theatre

Moderator


The National Alliance for the Mentally Ill

Member


Psychopharmacologic Drugs

Member of the Advisory Committee


Neuropharmacologic

Member of the Advisory Committee


Advisory Committee for Neuropharmacologic

Member


Bronx Psychiatric Center

Research Fellow


Congress Patrick Kennedy

Member


Johnson & Johnson Inc

Advisor Or Consultant


Janssen

Advisor Or Consultant


Novartis AG

Advisor Or Consultant


Education

M.D.

Columbia University


M.D.

Duke University


M.D.

National Institute of Mental Health's CATIE study


M.D.

New York State Psychiatric Institute


M.D.'s hasty clarification of Insel's criticism


M.P.A.


MD

Little , Brown


MD

University of North Carolina at Chapel Hill


bachelor's degree

biology

Miami University of Oxford , Ohio


medical degree

George Washington School of Medicine


medical degree

George Washington University


Web References(196 Total References)


A Tale of Mysterious Coffins

mountvernonbaltimore.org [cached]

Jeffrey Lieberman, MD
In Shrinks, Jeffrey Lieberman, MD, shares the story of psychiatry's origins and the checkered history of useless or harmful treatments that made psychiatry the black sheep of medicine. Lieberman describes psychiatry's scientific rehabilitation, beginning after WWII, with the discipline's slow embrace of psychopharmacology, genetics, and neuroscience, and how it has been transformed into an evidence-based profession. Dr. Jeffrey Lieberman is former president of the American Psychiatric Association; Chairman of Psychiatry at Columbia University's College of Physicians and Surgeons; Psychiatrist in Chief at Columbia University Medical Center-New York Presbyterian Hospital; and Director of the New York State Psychiatric Institute.


Jeffrey Lieberman, M.D.

clintara.com [cached]

You are here: Home / Scientific Advisory Board / Jeffrey Lieberman, M.D.
Jeffrey Lieberman, M.D. Jeffrey Lieberman Clintara SAB Vice Chairman Lawrence C. Kolb Professor and Chairman of Psychiatry Jeffrey A. Lieberman, MD, is a physician and scientist who has spent his career of over 25 years caring for patients and studying the nature and treatment of mental illness. Jeffrey A. Lieberman, M.D., is the Lawrence C. Kolb Professor and Chairman of Psychiatry at the Columbia University College of Physicians and Surgeons and Director of the New York State Psychiatric Institute. He also holds the Lieber Chair for Schizophrenia Research in the Department of Psychiatry at Columbia and serves as Psychiatrist in Chief at NewYork-Presbyterian Hospital - Columbia University Medical Center. Dr. Lieberman received his medical degree from the George Washington School of Medicine in 1975. Following his postgraduate training in psychiatry at St. Vincent's Hospital and Medical Center of New York Medical College, he was on the faculties of the Albert Einstein College of Medicine and Mount Sinai School of Medicine. Prior to moving to Columbia University, he was Vice Chairman for Research and Scientific Affairs in the Department of Psychiatry and Director of the Mental Health and Neuroscience Center at the University of North Carolina at Chapel Hill School of Medicine. Dr. Lieberman's research has been supported by grants from the National Institutes of Health and the NARSAD, Stanley, and Mental Illness Foundations and has focused on the neurobiology, pharmacology and treatment of schizophrenia and related psychotic disorders. In this context, his work has advanced our understanding of the natural history and pathophysiology of schizophrenia and the pharmacology and clinical effectiveness of antipsychotic drugs. In terms of the latter, he served as Principal Investigator of the Clinical Antipsychotic Trials of Intervention Effectiveness Research Program (CATIE), sponsored by the NIMH. He also currently serves as Principal Investigator on the newly awarded NIMH contract Recovery After an Initial Schizophrenic Episode (RAISE) and will lead a multi-institution research team in developing and testing an evidence-based strategic intervention for early psychosis to demonstrate how treatment at the onset of symptoms can prevent the debilitating effects of schizophrenia and related psychotic disorders. His work has been reported in more than 450 articles in the scientific literature and he has edited or co-edited 12 books, including the textbook Psychiatry, currently in its third edition; Textbook of Schizophrenia, Comprehensive Care of Schizophrenia; Psychiatric Drugs; and Ethics in Psychiatric Research: A Resource Manual on Human Subjects Protection. He also serves, or has served, as Associate Editor of the American Journal of Psychiatry, Biological Psychiatry, Neuropsychopharmacology, Acta Psychiatrica Scandinavica, Schizophrenia Research, Neuroimage, International Journal of Neuropsychopharmacology, and the Schizophrenia Bulletin. Dr. Lieberman is a member of the National Academy of Sciences Institute of Medicine and a fellow of the American Association for the Advancement of Science (AAAS). He is a recipient of the Lieber Prize for Schizophrenia Research from NARSAD, the Adolph Meyer Award from the American Psychiatric Association, the Stanley R. Dean Award for Schizophrenia Research from the American College of Psychiatry, the APA Research Award, the APA Kempf Award for Research in Psychobiology, the APA Gralnick Award for Schizophrenia Research, the Ziskind-Somerfeld Award of the Society of Biological Psychiatry, the Ernest Strecker Award of the University of Pennsylvania, the Exemplary Psychiatrist Award from the National Alliance of the Mentally Ill, and the Lilly Neuroscience Award from the Collegium Internationale Neuro-Psychopharmacologicum for Clinical Research. He is or has been a member of the advisory committee for Neuropharmacologic and Psychopharmacologic Drugs of the Food and Drug Administration, the Planning Board for the Surgeon General's Report on Mental Health, the Committee on Research on Psychiatric Treatments of the American Psychiatric Association (APA), the APA Work Group for the Development of Schizophrenia Treatment Guidelines, the Brain Disorders and Clinical Neuroscience Review Committee, and the National Advisory Mental Health Council of the National Institute of Mental Health. He is currently Vice President of the Collegium Internationale Neuro-Psychopharmacologicum (CINP) and chairs the Council on Research and Quality Care for the American Psychiatric Association (APA). He resides with his wife and two sons in New York City. Jeffrey Lieberman, M.D.


Psychiatric Illnesses Have Power Over Sufferers

theundergroundsite.com [cached]

Suicide claims more than 38,000 American lives each year - more than the number killed by car accidents, according to the Centers for Disease Control and Prevention - and the rate hasn't budged in decades, said Jeffrey Lieberman, professor and chairman of psychiatry at New York's Columbia University College of Physicians and Surgeons.
Williams could put a human face on a problem that often gets little attention, Lieberman said.


Society for Research in Psychopathology

www.psychopathology.org [cached]

7. Jeffrey Lieberman [Columbia University]


Editors | Current Neurobiology | International Advisory Board

currentneurobiology.org [cached]

Jeffrey A. Lieberman
Lawrence C. Kolb Professor and Chairman of Psychiatry, Columbia University College of Physicians and Surgeons, Director, New York State Psychiatric Institute Psychiatrist-in-Chief, New York Presbyterian Hospital-Columbia University Medical Center New York


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory